Addex Therapeutics Ltd Research and Development Expense
Addex Therapeutics Ltd (ADXN) reported Research and Development Expense of CHF 234.45 thousand for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-09-30
- Addex Therapeutics Ltd research and development expense for the quarter ending 2025-06-30 was 234.45K CHF, a 30.90% decline year-over-year.
- Addex Therapeutics Ltd research and development expense for the quarter ending 2024-06-30 was 339.32K CHF, a 81.90% decline year-over-year.
- Addex Therapeutics Ltd research and development expense for the quarter ending 2023-06-30 was 1.88M CHF, a 67.37% decline year-over-year.
- Addex Therapeutics Ltd research and development expense for the quarter ending 2022-06-30 was 5.75M CHF, a 54.00% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | 234.45K CHF 6-K · filed 2025-09-30 | 390.52K CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 854.30K CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | 339.32K CHF 6-K · filed 2025-09-30 | 584.44K CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | 1.19M CHF 20-F · filed 2025-05-15 | 6.96M CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | 1.88M CHF 6-K/A · filed 2023-12-21 | 3.58M CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | 8.24M CHF 20-F · filed 2025-05-15 | 14.67M CHF 20-F · filed 2023-03-30 | ||
| 2022-06-30 | 5.75M CHF 6-K/A · filed 2023-12-21 | 9.51M CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 12.84M CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | 3.73M CHF 6-K/A · filed 2022-09-14 | 6.48M CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | 10.37M CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 12.45M CHF 20-F · filed 2022-03-10 | |||
| 2018-12-31 | 4.92M CHF 20-F · filed 2021-03-11 | |||
| 2017-12-31 | 2.63M CHF 20-F · filed 2020-04-27 |